{"id":"https://openalex.org/W2012872987","doi":"https://doi.org/10.1097/00002371-199811000-00001","title":"Peptide Vaccination with an Anchor-Replaced CTL Epitope Protects Against Human Papillomavirus Type 16-Induced Tumors Expressing the Wild-Type Epitope","display_name":"Peptide Vaccination with an Anchor-Replaced CTL Epitope Protects Against Human Papillomavirus Type 16-Induced Tumors Expressing the Wild-Type Epitope","publication_year":1998,"publication_date":"1998-11-01","ids":{"openalex":"https://openalex.org/W2012872987","doi":"https://doi.org/10.1097/00002371-199811000-00001","mag":"2012872987","pmid":"https://pubmed.ncbi.nlm.nih.gov/9807734"},"language":"en","primary_location":{"id":"doi:10.1097/00002371-199811000-00001","doi":"https://doi.org/10.1097/00002371-199811000-00001","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00002371-199811000-00001","pdf_url":null,"source":{"id":"https://openalex.org/S177451610","display_name":"Journal of Immunotherapy","issn_l":"1524-9557","issn":["1524-9557","1537-4513"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Immunotherapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069049117","display_name":"Michel Vierboom","orcid":"https://orcid.org/0000-0002-1865-7532","observed_orcids":["https://orcid.org/0000-0002-1865-7532"]},"institutions":[{"id":"https://openalex.org/I2800006345","display_name":"Leiden University Medical Center","ror":"https://ror.org/05xvt9f17","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2800006345"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"Michel P. M. Vierboom","raw_affiliation_strings":["Department of Immunohematology & Blood Bank, University Hospital Leiden, The Netherlands","Department of Immunohematology & Blood Bank, University Hospital Leiden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Immunohematology & Blood Bank, University Hospital Leiden, The Netherlands","institution_ids":["https://openalex.org/I2800006345"]},{"raw_affiliation_string":"Department of Immunohematology & Blood Bank, University Hospital Leiden","institution_ids":["https://openalex.org/I2800006345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013565387","display_name":"Mariet C.W. Feltkamp","orcid":"https://orcid.org/0000-0001-5993-9846","observed_orcids":["https://orcid.org/0000-0001-5993-9846"]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]},{"id":"https://openalex.org/I4210112943","display_name":"Department of Virology","ror":"https://ror.org/01xx2ne27","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I157536573","https://openalex.org/I4210096427","https://openalex.org/I4210112943"]}],"countries":["FR","NL"],"is_corresponding":false,"raw_author_name":"Mariet C. W. Feltkamp","raw_affiliation_strings":["Department of Virology, Academic Medical Centre"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Virology, Academic Medical Centre","institution_ids":["https://openalex.org/I2802928900","https://openalex.org/I4210112943"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082388604","display_name":"Anne Neisig","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1925986","display_name":"Loyola University Chicago","ror":"https://ror.org/04b6x2g63","country_code":"US","type":"education","lineage":["https://openalex.org/I1925986"]},{"id":"https://openalex.org/I2800006345","display_name":"Leiden University Medical Center","ror":"https://ror.org/05xvt9f17","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2800006345"]},{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL","US"],"is_corresponding":true,"raw_author_name":"Anne Neisig","raw_affiliation_strings":["Department of Cellular Biochemistry, Netherlands Cancer Institute, Amsterdam, The Netherlands","Department of Cellular Biochemistry, Netherlands Cancer Institute, Amsterdam, The Netherlands; and \u00a7Cancer Immunology Program, Cardinal Bernardin Cancer Center, Loyola University of Chicago, Maywood, Illinois, U.S.A","Department of Immunohematology & Blood Bank, University Hospital Leiden","\u00a7Cancer Immunology Program, Cardinal Bernardin Cancer Center, Loyola University of Chicago, Maywood, Illinois, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cellular Biochemistry, Netherlands Cancer Institute, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2898336195"]},{"raw_affiliation_string":"Department of Cellular Biochemistry, Netherlands Cancer Institute, Amsterdam, The Netherlands; and \u00a7Cancer Immunology Program, Cardinal Bernardin Cancer Center, Loyola University of Chicago, Maywood, Illinois, U.S.A","institution_ids":["https://openalex.org/I1925986","https://openalex.org/I2898336195"]},{"raw_affiliation_string":"Department of Immunohematology & Blood Bank, University Hospital Leiden","institution_ids":["https://openalex.org/I2800006345"]},{"raw_affiliation_string":"\u00a7Cancer Immunology Program, Cardinal Bernardin Cancer Center, Loyola University of Chicago, Maywood, Illinois, U.S.A","institution_ids":["https://openalex.org/I1925986"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021731198","display_name":"Jan Wouter Drijfhout","orcid":"https://orcid.org/0000-0003-4808-5296","observed_orcids":["https://orcid.org/0000-0003-4808-5296"]},"institutions":[{"id":"https://openalex.org/I2800006345","display_name":"Leiden University Medical Center","ror":"https://ror.org/05xvt9f17","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2800006345"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"Jan Wouter Drijfhout","raw_affiliation_strings":["Department of Immunohematology & Blood Bank, University Hospital Leiden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Immunohematology & Blood Bank, University Hospital Leiden","institution_ids":["https://openalex.org/I2800006345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009426444","display_name":"Jan ter Schegget","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]},{"id":"https://openalex.org/I4210112943","display_name":"Department of Virology","ror":"https://ror.org/01xx2ne27","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I157536573","https://openalex.org/I4210096427","https://openalex.org/I4210112943"]}],"countries":["FR","NL"],"is_corresponding":false,"raw_author_name":"Jan ter Schegget","raw_affiliation_strings":["Department of Virology, Academic Medical Centre"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Virology, Academic Medical Centre","institution_ids":["https://openalex.org/I2802928900","https://openalex.org/I4210112943"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060457244","display_name":"Jacques Neefjes","orcid":"https://orcid.org/0000-0001-6763-2211","observed_orcids":["https://orcid.org/0000-0001-6763-2211"]},"institutions":[{"id":"https://openalex.org/I1925986","display_name":"Loyola University Chicago","ror":"https://ror.org/04b6x2g63","country_code":"US","type":"education","lineage":["https://openalex.org/I1925986"]},{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL","US"],"is_corresponding":false,"raw_author_name":"Jacques J. Neefjes","raw_affiliation_strings":["Department of Cellular Biochemistry, Netherlands Cancer Institute, Amsterdam, The Netherlands","Department of Cellular Biochemistry, Netherlands Cancer Institute, Amsterdam, The Netherlands; and \u00a7Cancer Immunology Program, Cardinal Bernardin Cancer Center, Loyola University of Chicago, Maywood, Illinois, U.S.A","\u00a7Cancer Immunology Program, Cardinal Bernardin Cancer Center, Loyola University of Chicago, Maywood, Illinois, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cellular Biochemistry, Netherlands Cancer Institute, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2898336195"]},{"raw_affiliation_string":"Department of Cellular Biochemistry, Netherlands Cancer Institute, Amsterdam, The Netherlands; and \u00a7Cancer Immunology Program, Cardinal Bernardin Cancer Center, Loyola University of Chicago, Maywood, Illinois, U.S.A","institution_ids":["https://openalex.org/I1925986","https://openalex.org/I2898336195"]},{"raw_affiliation_string":"\u00a7Cancer Immunology Program, Cardinal Bernardin Cancer Center, Loyola University of Chicago, Maywood, Illinois, U.S.A","institution_ids":["https://openalex.org/I1925986"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035565968","display_name":"Cornelis J.M. Melief","orcid":"https://orcid.org/0000-0001-5709-3584","observed_orcids":["https://orcid.org/0000-0001-5709-3584","https://orcid.org/0000-0003-0741-2094"]},"institutions":[{"id":"https://openalex.org/I2800006345","display_name":"Leiden University Medical Center","ror":"https://ror.org/05xvt9f17","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2800006345"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"Cornelis J. M. Melief","raw_affiliation_strings":["Department of Immunohematology & Blood Bank, University Hospital Leiden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Immunohematology & Blood Bank, University Hospital Leiden","institution_ids":["https://openalex.org/I2800006345"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5048611754","display_name":"W. Martin Kast","orcid":"https://orcid.org/0000-0003-2321-3159","observed_orcids":["https://orcid.org/0000-0003-2321-3159"]},"institutions":[{"id":"https://openalex.org/I1925986","display_name":"Loyola University Chicago","ror":"https://ror.org/04b6x2g63","country_code":"US","type":"education","lineage":["https://openalex.org/I1925986"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"W. Martin Kast","raw_affiliation_strings":["Cancer Immunology Program, Cardinal Bernardin Cancer Center, Loyola University of Chicago, Maywood, Illinois, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Immunology Program, Cardinal Bernardin Cancer Center, Loyola University of Chicago, Maywood, Illinois, U.S.A","institution_ids":["https://openalex.org/I1925986"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5021731198","https://openalex.org/A5035565968","https://openalex.org/A5069049117","https://openalex.org/A5082388604"],"corresponding_institution_ids":["https://openalex.org/I1925986","https://openalex.org/I2800006345","https://openalex.org/I2898336195"],"apc_list":null,"apc_paid":null,"fwci":0.9379,"has_fulltext":false,"cited_by_count":35,"citation_normalized_percentile":{"value":0.7390008,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"21","issue":"6","first_page":"399","last_page":"408"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.8544999957084656,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.8544999957084656,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12576","display_name":"vaccines and immunoinformatics approaches","score":0.14259999990463257,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/peptide-vaccination","display_name":"peptide vaccination","score":0.7789999842643738},{"id":"https://openalex.org/keywords/ctl-epitopes","display_name":"CTL epitopes","score":0.7620000243186951},{"id":"https://openalex.org/keywords/anchor-residues","display_name":"anchor residues","score":0.7250000238418579},{"id":"https://openalex.org/keywords/mhc-class-i-binding","display_name":"MHC class I binding","score":0.8500000238418579},{"id":"https://openalex.org/keywords/h-2db","display_name":"H-2Db","score":0.847000002861023},{"id":"https://openalex.org/keywords/epitope-based-vaccine","display_name":"epitope-based vaccine","score":0.574999988079071},{"id":"https://openalex.org/keywords/tumor-protection","display_name":"tumor protection","score":0.6489999890327454},{"id":"https://openalex.org/keywords/antigen-presentation","display_name":"antigen presentation","score":0.367000013589859},{"id":"https://openalex.org/keywords/immunogenicity","display_name":"immunogenicity","score":0.7459999918937683}],"concepts":[{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.9766590595245361},{"id":"https://openalex.org/C147969180","wikidata":"https://www.wikidata.org/wiki/Q5014579","display_name":"CTL*","level":4,"score":0.867307186126709},{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.6791510581970215},{"id":"https://openalex.org/C170627219","wikidata":"https://www.wikidata.org/wiki/Q13218497","display_name":"MHC class I","level":4,"score":0.6416633725166321},{"id":"https://openalex.org/C207936829","wikidata":"https://www.wikidata.org/wiki/Q423163","display_name":"Major histocompatibility complex","level":3,"score":0.6174479722976685},{"id":"https://openalex.org/C78598654","wikidata":"https://www.wikidata.org/wiki/Q17140316","display_name":"Linear epitope","level":4,"score":0.5254149436950684},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.5205250978469849},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.48626577854156494},{"id":"https://openalex.org/C2779026604","wikidata":"https://www.wikidata.org/wiki/Q4774742","display_name":"Antigenicity","level":3,"score":0.47915762662887573},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4663606882095337},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.46395817399024963},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.45578259229660034},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.4037815034389496},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.22517627477645874},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.21008658409118652},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.1278468370437622}],"mesh":[{"descriptor_ui":"D000595","descriptor_name":"Amino Acid Sequence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000937","descriptor_name":"Antigen-Antibody Reactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000939","descriptor_name":"Epitopes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002472","descriptor_name":"Cell Transformation, Viral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003429","descriptor_name":"Cross Reactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D013602","descriptor_name":"T-Lymphocytes, Cytotoxic","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D014412","descriptor_name":"Tumor Virus Infections","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D014611","descriptor_name":"Vaccination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015395","descriptor_name":"Histocompatibility Antigens Class I","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D027383","descriptor_name":"Papillomaviridae","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D030361","descriptor_name":"Papillomavirus Infections","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00002371-199811000-00001","doi":"https://doi.org/10.1097/00002371-199811000-00001","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00002371-199811000-00001","pdf_url":null,"source":{"id":"https://openalex.org/S177451610","display_name":"Journal of Immunotherapy","issn_l":"1524-9557","issn":["1524-9557","1537-4513"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Immunotherapy","raw_type":"journal-article"},{"id":"pmid:9807734","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9807734","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of immunotherapy (Hagerstown, Md. : 1997)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2045643921","display_name":"TRANSFORMING GENES AND IMMUNOLOGICAL TUMOR REGRESSION","funder_award_id":"P01CA074182","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G2331587373","display_name":"HPV AND ANTIGEN PRESENTING CELLS","funder_award_id":"R01CA074397","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1978146796","https://openalex.org/W7203838338","https://openalex.org/W2101676174","https://openalex.org/W1946675397","https://openalex.org/W1607711284","https://openalex.org/W1975135634","https://openalex.org/W2380647059","https://openalex.org/W2010402241","https://openalex.org/W2151861625","https://openalex.org/W1997729487"],"abstract_inverted_index":{"Anchor":[0],"residues":[1,106,117],"in":[2,11,65,229],"cytotoxic":[3],"T-lymphocyte":[4],"(CTL)":[5],"epitope-bearing":[6],"peptides":[7],"are":[8,22,113,208,234],"buried":[9],"deep":[10],"the":[12,38,77,91,124,137,141,158,166,185,192],"major":[13],"histocompatibility":[14],"complex":[15],"(MHC)":[16],"class":[17,28,51,126,214],"I":[18,29,52,127,215],"antigen-presenting":[19],"groove":[20],"and":[21,47,54,61,74,170,217,227],"essential":[23],"for":[24,88],"binding":[25,122,216],"to":[26,44,123,212,225,236],"MHC":[27,50,125,213],"molecules.":[30],"We":[31],"investigated":[32],"whether":[33],"anchor":[34,69,102,206],"residue":[35],"replacement":[36,100],"affects":[37,62],"ability":[39],"of":[40,76,90,176],"a":[41,180],"CTL":[42,79,154,164,204,237],"epitope":[43,80,187,194,205],"be":[45],"bound":[46],"transported":[48],"by":[49,134],"molecules":[53],"transporter":[55],"associated":[56],"with":[57,105,136,182,210,223],"antigen":[58],"(TAP),":[59],"respectively,":[60],"its":[63],"functionality":[64],"vivo.":[66,230],"Therefore,":[67],"both":[68],"residues,":[70],"at":[71,101,118],"positions":[72],"5":[73],"9,":[75],"H-2Db-restricted":[78],"HPV16":[81],"E7":[82,195],"49-57":[83],"RAHYNIVTF":[84],"were":[85],"systematically":[86],"exchanged":[87],"one":[89],"19":[92],"other":[93],"naturally":[94],"occurring":[95],"amino":[96],"acid":[97],"(AA).":[98],"Only":[99],"position":[103],"9":[104],"V,":[107],"I,":[108],"L,":[109],"or":[110],"M,":[111],"which":[112],"documented":[114],"Db":[115],"motif-anchor":[116],"that":[119,155,202],"position,":[120],"allowed":[121,209],"H-2Db":[128],"molecule":[129],"as":[130,132,140,189,191,220,222],"well":[131,221],"transport":[133],"TAP":[135,218],"same":[138],"efficiency":[139],"wild-type":[142,159,162,193],"epitope.":[143,160],"In":[144,174],"B6":[145],"mice":[146],"(H-2b),":[147],"these":[148],"anchor-modified":[149],"peptide":[150,239],"epitopes":[151],"efficiently":[152],"induced":[153],"specifically":[156],"recognized":[157,165],"Conversely,":[161],"epitope-induced":[163],"V9-,":[167],"I9-,":[168],"L9-,":[169],"M9-replaced":[171],"epitopes,":[172],"respectively.":[173],"terms":[175],"tumor":[177],"protection":[178],"against":[179],"challenge":[181],"HPV16-transformed":[183],"cells,":[184],"V9-replaced":[186],"was":[188],"efficient":[190],"49-57.":[196],"Taken":[197],"together,":[198],"our":[199],"data":[200],"demonstrate":[201],"specific":[203],"replacements":[207],"respect":[211,224],"transport,":[219],"antigenicity":[226],"immunogenicity":[228],"The":[231],"results":[232],"presented":[233],"relevant":[235],"epitope-based":[238],"vaccine":[240],"development.":[241]},"counts_by_year":[{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}